Evidence map›Paper›PMID 27983650›Full record

ArticleInternational journal of molecular sciences2016

Discovery of Anti-Hypertensive Oligopeptides from Adlay Based on In Silico Proteolysis and Virtual Screening.

Liansheng Qiao, Bin Li, Yankun Chen, Lingling Li, Xi Chen, Lingzhi Wang, Fang Lu, Ganggang Luo, Gongyu Li, Yanling Zhang

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
6.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 35 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. A Novel Gelatinase from MarineMarine drugs · 2022
    Article
  6. The etiology of Bell's palsy: a review.Journal of neurology · 2020
    Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 1 country.

Liansheng QiaoKey Laboratory of TCM Foundation and New Drug Research, School of Chinese Material Medica, University of Chinese Medicine, Beijing 100102, China. b20100222012@163.com.
Bin LiKey Laboratory of TCM Foundation and New Drug Research, School of Chinese Material Medica, University of Chinese Medicine, Beijing 100102, China. libinzyy@163.com.
Yankun ChenKey Laboratory of TCM Foundation and New Drug Research, School of Chinese Material Medica, University of Chinese Medicine, Beijing 100102, China. 18811791975@163.com.
Lingling LiKey Laboratory of TCM Foundation and New Drug Research, School of Chinese Material Medica, University of Chinese Medicine, Beijing 100102, China. lilingling94@126.com.
Xi ChenKey Laboratory of TCM Foundation and New Drug Research, School of Chinese Material Medica, University of Chinese Medicine, Beijing 100102, China. chenxi_cx95@163.com.
Lingzhi WangKey Laboratory of TCM Foundation and New Drug Research, School of Chinese Material Medica, University of Chinese Medicine, Beijing 100102, China. wanglz@bucm.edu.cn.
Fang LuKey Laboratory of TCM Foundation and New Drug Research, School of Chinese Material Medica, University of Chinese Medicine, Beijing 100102, China. lufang1017@163.com.
Ganggang LuoKey Laboratory of TCM Foundation and New Drug Research, School of Chinese Material Medica, University of Chinese Medicine, Beijing 100102, China. 17801080765@163.com.
Gongyu LiKey Laboratory of TCM Foundation and New Drug Research, School of Chinese Material Medica, University of Chinese Medicine, Beijing 100102, China. lidoc2727@163.com.
Yanling ZhangKey Laboratory of TCM Foundation and New Drug Research, School of Chinese Material Medica, University of Chinese Medicine, Beijing 100102, China. zhangyanling@bucm.edu.cn.
Beijing University of Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Adlay (

Indexed as

Computer SimulationDrug DiscoveryDrug Evaluation, PreclinicalProteolysisUser-Computer InterfaceAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsChromatography, High Pressure LiquidChromatography, Reverse-PhaseCoixCrystallography, X-RayDatabases, ProteinMolecular Docking SimulationOligopeptidesPeptide LibraryTime FactorsAngiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsOligopeptidesPeptide Libraryadlayangiotensin-I converting enzyme (ACE)hypertensionin silico proteolysismolecular dynamics (MD)oligopeptides

Identifiers

PMID27983650
PMCPMC5187899
OpenAlexW2560854693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.